Strategically incorporating color in health care spaces can potentially increase patient comfort and improve overall ...

KONFIDENT phase 3 trial results demonstrated significantly faster symptom relief with sebetralstat compared to placebo.

Some patients with psoriasis who were treated with guselkumab and achieved complete skin clearance experienced a persistent impact on quality of life.

Immunosuppressive therapy may help reduce gastrointestinal (GI) symptoms among patients with systemic sclerosis (SSc), according to study results published in RMD Open.

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is moderately effective against mpox infection in at-risk communities.

The incidence of melanoma was always highest on the trunk in men, while in women, incidence was historically highest on limbs, but recent increases in truncal melanoma were seen. HealthDay News — ...

Dupilumab decreases general and type 2 inflammatory biomarker levels in children with moderate to severe atopic dermatitis.

ED admission rates are significantly higher in pediatric patients with vs without dystrophic epidermolysis bullosa.

Increasing clinical evidence links changes in the composition of the gut microbiome to the development of various skin diseases such as eczema.

Photodynamic therapy and radiofrequency devices had consistent reductions in causal sebum levels among patients with acne vulgaris.

For adults aged 30 to 49 years, there has been a decline in melanoma incidence and mortality, according to study findings.